Related Experiment Video
Updated: Jul 8, 2026
06:58
Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement
Published on: June 25, 2016
New-onset seizures: a possible association with clonidine?
Frans J M Feron1, Jos G M Hendriksen, Joost Nicolai
1Youth Health Care Division, Regional Public Health Institute Maastricht, Department of Child Neurology, University Hospital Maastricht, The Netherlands. frans.feron@ggdzl.nl
Pediatric Neurology
|January 22, 2008
Summary
Clonidine, a second-line ADHD medication, may be associated with new-onset seizures in children. This case report highlights a potential risk even at therapeutic doses, warranting further investigation in pediatric epilepsy.
Area of Science:
- Pediatric Neurology
- Pharmacology
- Epileptology
Background:
- Clonidine is a second-line treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children.
- Current product information suggests seizures are primarily linked to clonidine overdosage.
- Clonidine is not contraindicated in patients with a history of epilepsy.
Observation:
- A 9-year-old girl experienced new-onset seizures.
- The patient was being treated with clonidine for ADHD.
- The seizures occurred in the context of status epilepticus.
Findings:
- This case report suggests a potential association between therapeutic doses of clonidine and new-onset seizures.
- The event occurred in a pediatric patient with no prior history of epilepsy.
- Status epilepticus was the presenting seizure manifestation.
Implications:
- This case raises awareness about a potential, previously underreported adverse effect of clonidine in children.
- Further research is needed to elucidate the relationship between clonidine and seizure risk in pediatric populations.
- Clinicians should consider clonidine as a potential trigger for seizures in children, particularly those presenting with status epilepticus.
Related Concept Videos
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
01:20Seizures l: Introduction
Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
01:13Seizures: Classification
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
01:19Seizures ll: Types
Seizures are sudden bursts of abnormal electrical discharge in the brain that interfere with normal function. They are commonly divided into three groups: focal seizures, generalized seizures, and other types that do not fit neatly into either category.Focal SeizuresFocal seizures begin in a single brain region. When awareness is preserved, they are called focal aware seizures and may cause sensations such as tingling, unusual smells, or flashing lights. When awareness is impaired, they are...
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...